» Articles » PMID: 6203593

Hyperalgesia Produced by Intrathecal Substance P and Related Peptides: Desensitization and Cross Desensitization

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1984 Jun 1
PMID 6203593
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The hyperalgesic effect of intrathecally administered substance P (SP), physalaemin, eledoisin and eledoisin-related peptide (ERP) was investigated in the rat tail flick test. Hyperalgesia produced by SP (2.5-15 micrograms, 1.9-11 nmol) was maximal 10-20 min after injection, lasted 30 min and was dose-related. The effect was mimicked by all of the peptides examined. The rank order of potency was physalaemin greater than SP greater than eledoisin greater than ERP. Desensitization to the hyperalgesic effect of SP was produced by three repeated intrathecal injections. Rats desensitized to SP no longer responded to physalaemin or ERP, indicating cross-desensitization. Phentolamine continued to produce hyperalgesia following such desensitization. The demonstration of a hyperalgesic effect for SP provides further support for a role for SP in nociceptive transmission. The receptor mediating this effect appears to be a SP-P subtype. Cross-desensitization between peptides suggests an action on the same receptor.

Citing Articles

Opioids Resistance in Chronic Pain Management.

Morrone L, Scuteri D, Rombola L, Mizoguchi H, Bagetta G Curr Neuropharmacol. 2017; 15(3):444-456.

PMID: 28503117 PMC: 5405610. DOI: 10.2174/1570159X14666161101092822.


Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.

Ko M, Naughton N J Pain. 2009; 10(5):509-16.

PMID: 19231294 PMC: 2797530. DOI: 10.1016/j.jpain.2008.11.006.


Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.

Yamamoto T, Nair P, Davis P, Ma S, Navratilova E, Moye S J Med Chem. 2007; 50(12):2779-86.

PMID: 17516639 PMC: 2365895. DOI: 10.1021/jm061369n.


Contribution of substance P and neurokinin A to the differential injury-induced thermal and mechanical responsiveness of lamina I and V neurons.

Mazario J, Basbaum A J Neurosci. 2007; 27(4):762-70.

PMID: 17251415 PMC: 6672913. DOI: 10.1523/JNEUROSCI.2992-06.2007.


Role of NK-1 neurotransmission in opioid-induced hyperalgesia.

King T, Gardell L, Wang R, Vardanyan A, Ossipov M, Malan Jr P Pain. 2005; 116(3):276-288.

PMID: 15964684 PMC: 1440305. DOI: 10.1016/j.pain.2005.04.014.


References
1.
Lembeck F, Fischer G . [Crossed tachyphylaxis of peptides]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967; 258(5):452-6. View

2.
Konishi S, Otsuka M . The effects of substance P and other peptides on spinal neurons of the frog. Brain Res. 1974; 65(3):397-410. DOI: 10.1016/0006-8993(74)90231-5. View

3.
Konishi S, Otsuka M . Excitatory action of hypothalamic substance P on spinal motoneurones of newborn rats. Nature. 1974; 252(5485):734-5. DOI: 10.1038/252734a0. View

4.
Hokfelt T, Kellerth J, Nilsson G, PERNOW B . Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res. 1975; 100(2):235-52. DOI: 10.1016/0006-8993(75)90481-3. View

5.
Frederickson R, Burgis V, Harrell C, Edwards J . Dual actions of substance P on nociception: possible role of endogenous opioids. Science. 1978; 199(4335):1359-62. DOI: 10.1126/science.204012. View